Yes. Thomas Carper disclosed 2 purchases and 1 sale of Abbott Laboratories (ABT) stock between Feb 12, 2015 and Jan 17, 2024, in STOCK Act reports. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $1K-$15K.
Yes. Thomas Carper disclosed 2 purchases and 1 sale of Abbott Laboratories (ABT) stock between Feb 12, 2015 and Jan 17, 2024, in STOCK Act reports. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $1K-$15K.
How big were Thomas Carper's Abbott Laboratories trades?
STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $1K-$15K.
Did Thomas Carper make these Abbott Laboratories trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does Thomas Carper still own Abbott Laboratories stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did Thomas Carper report these trades?
The latest filing is dated Feb 2, 2024. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.
Reported trades and amount ranges, not what is held today. Reports can include a spouse and dependent children.
Loading